 comparison intraven bolu inject continu infus recombin singl chain urokinase-typ plasminogen activ saruplas thrombolysi canin model combin coronari arteri femor venou thrombosi thrombolyt efficaci recombin unglycosyl full length singl chain urokinase-typ plasminogen activ rscu-pa saruplas singl intraven bolu continu infus minut random group dog combin copper coil coronari arteri thrombosi label femor vein clot infus mg/kg recu-pa group coronari recan dog mean sem venou clot lysi inject mg/kg recu-pa group II reflow dog percent venou clot lysi infus mg/kg rescu-pa group iii reflow dog venou clot lysi inject mg/kg rscu-pa group IV reflow dog venou clot lysi placebo infus group late recan dog venou clot lysi coronari arteri reocclus reflow group II anim group iii anim group IV time respons anim minut infus mg/kg rscu-pa minut bolu inject mg/kg deplet fibrinogen alpha baselin level dog mg/kg rscu-pa bolu dog mg/kg rscu-pa infus none dog mg/kg rscu-pa plasma clearanc rate ml/minut bolu inject ml/minut infus rscu-pa mg/kg mg/kg dose intraven inject rscu-pa saruplas equipot infus minut coronari venou thrombolysi anim model combin arteri venou thrombolysi use evalu new thrombolyt strategi